Six things to know:
1. Total revenue grew 4.9 percent year-over-year.
2. Knee sales were $771.4 million, a 9.4 percent increase from the second quarter of 2022. Hip sales rose 3.5 percent with $504.3 million.
3. Sports medicine, extremities, trauma, craniomaxillofacial and thoracic sales were $442.7 million, a 0.8 percent decrease year-over-year.
4. The company saw net earnings of $209.6 million in the second quarter.
5. For the second half of 2023, total sales were $3.7 billion, a 7.4 percent increase year-over-year.
6. Zimmer Biomet is raising its 2023 guidance and projecting a 6.5 percent to seven percent in full-year revenue compared to 2022.
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.